ERU611 - REGISTRATION of BIOLOGICAL PRODUCTS

Course Name Code Semester Theory
(hours/week)
Application
(hours/week)
Credit ECTS
REGISTRATION of BIOLOGICAL PRODUCTS ERU611 Spring 2 2 3 6
Prequisites
Course languageTurkish
Course typeElective 
Mode of DeliveryFace-to-Face 
Learning and teaching strategiesLecture
Discussion
Drill and Practice
 
Instructor (s)Prof.Dr. Sevda Åženel 
Course objectiveTo be able to advance those who will work in the field of licensing biological products in terms of technological and preclinical information. 
Learning outcomes
  1. To be able to advance those who will work in the field of licensing biological products in terms of technological and preclinical information.
Course Content- Definitions related to biological products
- Development and production of biological products (vaccines, allergens, blood products etc.),
- Evaluation of biological products with technological aspects
- Pre-clinical (preclinical) evaluation methods of biological products
- National regulations on licensing biological products
- International regulations on licensing biological products
- Biosimilar drugs and their licensing
 
References- Rasyonel tedavi yönünden Tıbbi Farmakoloji (Prof. Dr. Oğuz Kayaalp),
- Klinik Farmakolojinin Esasları (Prof. Dr. Oğuz Kayaalp),
- Türkiye İlaç Kılavuzu
- Drug Information Handbook,
- PDR 2006
- EMA guidelines and directives
- FDA guidelines
- Turkish Medicines and Medical Devices Agency regulations 

Course outline weekly

WeeksTopics
Week 1Introduction to biological products; basic properties and classification of biological products
Week 2Technological factors in formulation of biological products (formulation development, manufacturing)
Week 3National and international regulations regarding the licensing of biological products
Week 4Pharmacology, toxicology and safety of biological products: vaccines
Week 5Pharmacology, toxicology and reliability of biological products: blood products.
Week 6Vaccine products and legal regulations
Week 7Midterm Exam
Week 8Biosimilars
Week 9Licensing of biosimilar products
Week 10Blood, serum and allergen products and legal regulations:
Week 11Production processes of biological products
Week 12Validation and GMP in biological products
Week 13Assignment presentation
Week 14Discussion
Week 15Final xam

Assesment methods

Course activitiesNumberPercentage
Attendance00
Laboratory00
Application00
Field activities00
Specific practical training00
Assignments00
Presentation00
Project00
Seminar00
Midterms150
Final exam150
Total100
Percentage of semester activities contributing grade succes150
Percentage of final exam contributing grade succes150
Total100

WORKLOAD AND ECTS CALCULATION

Activities Number Duration (hour) Total Work Load
Course Duration (x14) 14 2 28
Laboratory 0 0 0
Application14228
Specific practical training000
Field activities000
Study Hours Out of Class (Preliminary work, reinforcement, ect)14114
Presentation / Seminar Preparation000
Project000
Homework assignment000
Midterms (Study duration)15050
Final Exam (Study duration) 16060
Total Workload44115180

Matrix Of The Course Learning Outcomes Versus Program Outcomes

D.9. Key Learning OutcomesContrubition level*
12345
1. Has basic theoretical concepts and related approaches to provide quality in control systems used in analytical data and method validationsX    
2. Has capability to decide conformity tests and to evaluate results by arranging different conditions, planning the activities for method validation and quality controlX    
3. Has able to evaluate statistical data used for licensing medicinal products  X  
4. Has knowledge on the definition of drug, formulations, properties, production and quality controls    X
5. Has knowledge on pharmaceutical technology in evaluating and/or preparing application dossier of licensing medicines    X
6. Has pharmacological and toxicological knowledge for licensing medicinal products    X
7. Has satisfied knowledge on safely usage of medicines.  X  
8. Has basic and technical knowledge about radiopharmaceutics; preparing, evaluating and resulting ability for applied license dossier of radiopharmaceuticals. X    
9. Capable to perform researches on different subjects; can follow published scientific studies; can plan and end a research; able to write a report with the data.     X
10. Has a general idea on pharmaceutical biotechnology. X    
11. Has basic and important pharmacological and toxicological knowledge on biological products.    X
12. Has a general knowledge in registration of natural medicines, medicine out products, cosmetics, and food supplements. X   
13. Capable to discuss and/or defend pharmacoeconomic data in medicine licensing.   X  
14. Has basic and technical knowledge about radiopharmacy and has foreknowledge required for prepartio of license dossier of radiopharmaceuticals about radiopharmacy.     

*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest